Literature DB >> 1504751

The effect of neosurugatoxin on the release of neurohypophysial hormones by nicotine, hypotension and an osmotic stimulus in the rat.

G W Bisset1, K M Fairhall, K Tsuji.   

Abstract

1. Experiments were carried out to test whether neosurugatoxin (NSTX) which blocks autonomic ganglia also acts centrally, like hexamethonium, on nicotinic cholinoceptors involved in the neural control of release of vasopressin and oxytocin from the neurohypophysis. 2. In the water-loaded rat under ethanol anaesthesia, nicotine 100 micrograms i.v. produced a pressor and an antidiuretic response accompanied by an increase in the urinary excretion of vasopressin and of oxytocin-like radioimmunoreactivity (OLRI). This indicates release of both vasopressin and oxytocin. 3. Under conditions in which tachyphylaxis was avoided, NSTX, 80 ng i.c.v., caused a prolonged inhibition of the release of both hormones by nicotine. 4. NSTX i.c.v. caused some reduction in the pressor response to nicotine. It is suggested that this response involves both central and peripheral stimulation of the sympathetic nervous system and that the central component is blocked by neosurugatoxin. 5. Muscarine, 40 ng i.c.v., produced a pressor and an antidiuretic response with increased urinary excretion of vasopressin and OLRI. All these effects were blocked by atropine but were not inhibited by NSTX. 6. Sodium nitroprusside (SN), 200 micrograms i.v., and hypertonic saline (HS; 1.54 M NaCl solution) 4 microliters i.c.v., both produced antidiuretic responses accompanied by increased urinary excretion of vasopressin and OLRI. The ratio of the excretion of vasopressin to that of OLRI was 5.1 +/- 1.3 (mean +/- s.e.: n = 8) for SN and 1.2 +/- 0.24 (mean +/- s.e.: n = 6) for HS.NSTX 80 ng i.c.v., caused a significant reduction in the antidiuretic response to the hypotension induced with SN: the increased urinary excretion of vasopressin was also significantly reduced but not that of OLRI. NSTX had no effect on the response to HS.7. We conclude that NSTX acts centrally on nicotinic cholinoceptors to block the release of vasopressin and oxytocin by nicotine and the release of vasopressin, but not that of oxytocin, by hypotension. It does not inhibit the release of either hormone by a central osmotic stimulus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504751      PMCID: PMC1907556          DOI: 10.1111/j.1476-5381.1992.tb14395.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Neosurugatoxin: CNS acetylcholine receptors and luteinizing hormone secretion in ovariectomized rats.

Authors:  R B Billiar; J Kalash; V Romita; K Tsuji; T Kosuge
Journal:  Brain Res Bull       Date:  1988-03       Impact factor: 4.077

2.  A ganglion-blocking action of the toxin isolated from Japanese ivory shell (Babylonia japonica).

Authors:  H Hirayama; K Gogi; N Urakawa; M Ikeda
Journal:  Jpn J Pharmacol       Date:  1970-06

3.  Release of oxytocin and vasopressin in lactating rats after injection of carbachol into the third ventricle.

Authors:  E R Kuhn; S M McCann
Journal:  Neuroendocrinology       Date:  1971       Impact factor: 4.914

4.  Distribution of nicotinic binding sites with respect to CRF and neurophysin immunoreactive perikarya within the rat hypothalamus.

Authors:  B M Sharp; S Nicol; S Cummings; V Seybold
Journal:  Brain Res       Date:  1987-10-06       Impact factor: 3.252

5.  Effects of microelectrophoretically applied acetylcholine- and angiotensin-antagonists on the paraventricular neurosecretory cells excited by osmotic stimuli.

Authors:  T Akaishi; H Negoro
Journal:  Neurosci Lett       Date:  1983-04-11       Impact factor: 3.046

6.  A ganglion blocking action of toxic substances, IS-toxin and surugatoxin, from the Japanese ivory shell, Babylonia japonica.

Authors:  H Hirayama; K Sugihara; S Tsuyama; K Wakigawa; H Okuma
Journal:  Jpn J Pharmacol       Date:  1974-08

7.  Pharmacological studies on surugatoxin, the toxic principle from Japanese ivory mollusc (Babylonia japonica).

Authors:  E Hayashi; S Yamada
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

8.  Extra-hypothalamic afferent inputs to the supraoptic nucleus area of the rat as determined by retrograde and anterograde tracing techniques.

Authors:  E Tribollet; W E Armstrong; M Dubois-Dauphin; J J Dreifuss
Journal:  Neuroscience       Date:  1985-05       Impact factor: 3.590

9.  Staining of the magnocellular nuclei of the rat hypothalamus by a monoclonal antibody directed against the alpha-subunit of the nicotinic cholinergic receptor.

Authors:  W T Mason
Journal:  Neurosci Lett       Date:  1985-08-16       Impact factor: 3.046

10.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.

Authors:  P B Clarke; R D Schwartz; S M Paul; C B Pert; A Pert
Journal:  J Neurosci       Date:  1985-05       Impact factor: 6.167

View more
  3 in total

1.  Release of vasopressin and oxytocin by excitatory amino acid agonists and the effect of antagonists on release by muscarine and hypertonic saline, in the rat in vivo.

Authors:  G W Bisset; K M Fairhall
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

2.  Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.

Authors:  Sara E Wells; David M Flavell; Gordon W Bisset; Pamela A Houston; Helen Christian; Keith M Fairhall; Iain C A F Robinson
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

3.  Investigations into the construction of the penta-substituted ring C of Neosurugatoxin - a crystallographic study.

Authors:  Alan M Jones; John M D Storey; William T A Harrison
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.